Cargando…

Role and mechanism of programmed death-ligand 1 in hypoxia-induced liver cancer immune escape

Immune escape plays a vital role in the development of liver cancer. The interaction between programmed death-ligand 1 (PD-L1) and programmed cell death-1 is a key mediator of cancer immune escape, which leads to the suppression of anticancer immunity and promotion of tumor progression. Hypoxia is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Qingxian, Han, Tao, Wang, Zijian, Jiang, Shulong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068669/ https://www.ncbi.nlm.nih.gov/pubmed/32218809 http://dx.doi.org/10.3892/ol.2020.11369

Ejemplares similares

Hypoxia-Driven Immune Escape in the Tumor Microenvironment
por: Vito, Alyssa, et al.
Publicado: (2020)

Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis
por: Pancione, Massimo, et al.
Publicado: (2014)

Hypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape
por: Chouaib, Salem, et al.
Publicado: (2012)

ESCRT machinery: role of membrane repair mechanisms in escaping cell death
por: Gregor, Lisa, et al.
Publicado: (2022)

Na, K-ATPase α1 cooperates with its endogenous ligand to reprogram immune microenvironment of lung carcinoma and promotes immune escape
por: Yang, Kaiyong, et al.
Publicado: (2023)

Comprehensive insights into the effects and regulatory mechanisms of immune cells expressing programmed death-1/programmed death ligand 1 in solid tumors
por: Liu, Min, et al.
Publicado: (2020)

Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
por: Wu, Qinghua, et al.
Publicado: (2022)

Programmed Death Ligand 2 in Cancer-Induced Immune Suppression
por: Rozali, Esdy N., et al.
Publicado: (2012)

The roles and mechanisms of hypoxia in liver fibrosis
por: Cai, Jingyao, et al.
Publicado: (2021)

Role of immune escape in different digestive tumours
por: Du, Xin-Zhu, et al.
Publicado: (2021)

CD95 ligand expression mediates immune escape in breast cancer
por: Moers, C, et al.
Publicado: (2001)

The Immune Escape Mechanisms of Mycobacterium Tuberculosis
por: Zhai, Weijie, et al.
Publicado: (2019)

Emerging role of deubiquitination modifications of programmed death-ligand 1 in cancer immunotherapy
por: Jiang, Yao, et al.
Publicado: (2023)

Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
por: Yu, Wei-Bo, et al.
Publicado: (2019)

Liver kinase B1 in exosomes inhibits immune checkpoint programmed death ligand 1 and metastatic progression of intrahepatic cholangiocarcinoma
por: Liu, Zhuo, et al.
Publicado: (2022)

Inhibition of Death Receptor Signaling by Flice-Inhibitory Protein as a Mechanism for Immune Escape of Tumors
por: French, Lars E., et al.
Publicado: (1999)

KCNQ1OT1 contributes to sorafenib resistance and programmed death-ligand-1-mediated immune escape via sponging miR-506 in hepatocellular carcinoma cells
por: Zhang, Junli, et al.
Publicado: (2020)

The immune phenotypes and different immune escape mechanisms in colorectal cancer
por: Mao, Yihao, et al.
Publicado: (2022)

Role of autophagy on cancer immune escape
por: Duan, Yalan, et al.
Publicado: (2021)

Mechanisms of Senescence-Related NKG2D Ligands Release and Immune Escape Induced by Chemotherapy in Neuroblastoma Cells
por: Zhang, Yan, et al.
Publicado: (2022)

NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy
por: Schmiedel, Dominik, et al.
Publicado: (2018)

Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism
por: Labiano, Sara, et al.
Publicado: (2014)

Advances in research on immune escape mechanism of glioma
por: Guo, Xu, et al.
Publicado: (2023)

Role of programmed death ligands in effective T-cell interactions in extranodal natural killer/T-cell lymphoma
por: HAN, LIJUAN, et al.
Publicado: (2014)

Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas
por: Yang, Min-Wei, et al.
Publicado: (2019)

A critical role for the programmed death ligand 1 in fetomaternal tolerance
por: Guleria, Indira, et al.
Publicado: (2005)

Expression of Programmed Cell Death-Ligands in Hepatocellular Carcinoma: Correlation With Immune Microenvironment and Survival Outcomes
por: Liao, Haotian, et al.
Publicado: (2019)

The Great Escape: The Power of Cancer Stem Cells to Evade Programmed Cell Death
por: Castelli, Vanessa, et al.
Publicado: (2021)

Innate and adaptive immune escape mechanisms of hepatitis B virus
por: Zhao, Hua-Jun, et al.
Publicado: (2022)

The role of lysosomal peptidases in glioma immune escape: underlying mechanisms and therapeutic strategies
por: Liu, Hao, et al.
Publicado: (2023)

Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells
por: Kamata, Toshiko, et al.
Publicado: (2016)

Natural killer group 2D receptor and its ligands in cancer immune escape
por: Duan, Shixin, et al.
Publicado: (2019)

New Prognostic Gene Signature and Immune Escape Mechanisms of Bladder Cancer
por: Jiang, Yi, et al.
Publicado: (2022)

The role of the programmed cell death protein-1/programmed death-ligand 1 pathway, regulatory T cells and T helper 17 cells in tumor immunity: a narrative review
por: Zhang, Lanfang, et al.
Publicado: (2020)

Expression patterns of programmed death-1 and programmed death-1 ligand-1 on T cells in gastric cancer
por: Kim, Ji-Hyun, et al.
Publicado: (2019)

Programmed death‐ligand 1 expression in swine chronic infections and enhancement of interleukin‐2 production via programmed death‐1/programmed death‐ligand 1 blockade
por: Ganbaatar, Otgontuya, et al.
Publicado: (2021)

Elevated Expression of Programmed Death-1 and Programmed Death Ligand-1 Negatively Regulates Immune Response against Cervical Cancer Cells
por: Chen, Zhifang, et al.
Publicado: (2016)

Salmonella Virulence and Immune Escape
por: Wang, Mengyao, et al.
Publicado: (2020)

The predictive role of soluble programmed death ligand 1 in digestive system cancers
por: Ruan, Jian, et al.
Publicado: (2023)

Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma
por: Vanichapol, Thitinee, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_um0chch62mmq844cdk44q2h53q